Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 6:6:0275.
doi: 10.34133/cbsystems.0275. eCollection 2025.

Sex-Related Difference in Outcomes of Remote Ischemic Conditioning for Symptomatic Intracranial Atherosclerotic Stenosis

Affiliations

Sex-Related Difference in Outcomes of Remote Ischemic Conditioning for Symptomatic Intracranial Atherosclerotic Stenosis

Yuanyuan Liu et al. Cyborg Bionic Syst. .

Abstract

Remote ischemic conditioning (RIC) is a novel and promising therapeutic intervention for symptomatic intracranial atherosclerotic stenosis (sICAS). This study aimed to evaluate sex differences in stroke recurrence among patients with sICAS and assess the efficacy of RIC in the RICA (chronic remote ischemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis) trial. The RICA trial was a multicenter, randomized clinical trial conducted across 84 stroke centers in China. Patients with sICAS were randomly assigned on a 1:1 ratio to receive either RIC intervention or sham RIC intervention once daily for 12 months. The primary endpoint was ischemic stroke recurrence. The median follow-up duration was 3.5 years. Of the 3,033 patients enrolled in the RICA trial, 1,079 (35.58%) were women. Female patients were generally older (mean [SD] age 62.9 [8.8] years versus 60 [9.2] years) and had a higher prevalence of hypertension, diabetes, and a higher body mass index than male patients. No significant difference was observed in ischemic stroke recurrence risk between female and male patients during a median follow-up of 3.5 years (20.5% versus 16.6%, adjusted hazard ratio, 1.18; [95% CI, 0.97 to 1.42]). However, RIC significantly reduced the risk of ischemic stroke recurrence in male patients, while no similar effect was observed in female patients (adjusted hazard ratio, 0.88; [95% CI, 0.58 to 1.32]; P for interaction = 0.379). No significant sex-based differences were observed in ischemic stroke recurrence among patients with sICAS over the 3.5-year follow-up period. RIC may have better therapeutic benefits for male patients with good compliance.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1.
Fig. 1.
Association of sex with clinical outcomes in the intention-to-treat population. *Adjusted by age, body mass index, time from qualifying event to randomization, previous ischemic stroke, previous transient ischemic attack, previous myocardial infarction, systolic blood pressure, low-density lipoprotein cholesterol, fasting blood glucose, smoking status, symptomatic qualifying artery, and stenosis degree of qualifying artery.
Fig. 2.
Fig. 2.
Kaplan–Meier event curve for the primary endpoint and the composite secondary endpoint by sex in the per-protocol population. (A) Primary endpoint (ischemic stroke). (B) Composite secondary endpoint (stroke, transient ischemic attack, or myocardial infarction). RIC, remote ischemic conditioning; HR, hazard ratio.

Similar articles

Cited by

References

    1. Eren F, Yilmaz SE. Neuroprotective approach in acute ischemic stroke: A systematic review of clinical and experimental studies. Brain Circ. 2022;8(4):172–179. - PMC - PubMed
    1. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. - PMC - PubMed
    1. Gray LJ, Sprigg N, Bath PMW, Boysen G, De Deyn PP, Leys D, O’Neill D, Ringelstein EB, TAIST Investigators . Sex differences in quality of life in stroke survivors: Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke. 2007;38(11):2960–2964. - PubMed
    1. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, Khatiwoda A, Lisabeth L. Sex differences in stroke: Epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7(10):915–926. - PMC - PubMed
    1. Glader E-L, Stegmayr B, Norrving B, Terént A, Hulter-Asberg K, Wester P-O, Asplund K, Riks-Stroke Collaboration . Sex differences in management and outcome after stroke: A Swedish national perspective. Stroke. 2003;34(8):1970–1975. - PubMed

LinkOut - more resources